AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

NSABP protocol C-06: Oral chemotherapy equally effective and tolerated.

Vaccine Weekly

| July 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Five-year results of NSABP (National Surgical Adjuvant Breast and Bowel Project) Protocol C-06 that compared oral chemotherapy (UFT/leucovorin) with intravenous chemotherapy (5-FU/leucovorin) demonstrated no significant differences in disease-free survival (p=0.79) or overall survival (p=0.88) between the two treatment arms, with equal tolerability in patients with stage II-III colon cancer.

The findings were presented at the 40th American Society of Clinical Oncology annual meeting.

"These are significant findings because they reinforce the growing importance of oral chemotherapy in the treatment of colorectal cancer. Similar results have already been observed in metastatic disease, where oral UFT/LV has shown to be as effective as IV (intravenous) 5-FU/LV, but this evidence supports the use of oral chemotherapy at a much earlier stage in the disease process," said Dr. Norman Wolmark, chair of the NSABP, and the department of human oncology at Allegheny General Hospital in Pittsburgh, Pennsylvania, lead investigator.

"In addition these results contribute to a growing body of evidence in defining the role of adjuvant chemotherapy ...

Related articles from newspapers, magazines, journals, and more
Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment...
Newspaper article from: U.S. Newswire July 27, 2009 700+ words
...in Elizabeth, New Jersey has new oral chemotherapy program in place LOS ANGELES, July...The increasing availability of oral chemotherapy for treating a variety of cancers...risks and efficient management of oral chemotherapy. At Aptium Oncology's Trinitas...
Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment...
Newspaper article from: Cancer Weekly August 11, 2009 700+ words
...increasing availability of oral chemotherapy for treating a variety of...efficient management of oral chemotherapy. At Aptium Oncology's...the greater emergence of oral chemotherapy regimens is a significant...
ROCHE ORAL CHEMOTHERAPY FOR COLORECTAL CANCER STILL ON SCHEDULE WITH U.S.
Press release article from: PR Newswire March 27, 2001 700+ words
ROCHE ORAL CHEMOTHERAPY FOR COLORECTAL CANCER STILL ON...today that the review of its oral chemotherapy for colorectal cancer, Xeloda...cancer, making it the first oral chemotherapy approved in all the EU countries...
Non-Compliance with Oral Chemotherapy May Be a Cause of Late Relapse in...
Newspaper article from: Pediatric & Adolescent Medicine Reports March 1, 1997 700+ words
Non-Compliance with Oral Chemotherapy May Be a Cause of Late Relapse...malignancies may not take the oral chemotherapy medications that have been...L. Non-compliance with oral chemotherapy in childhood leukemia: An...
New York-Based Bristol-Myers Develops Oral Chemotherapy Drug.
Newspaper article from: Knight Ridder/Tribune Business News Carty, Sharon Silke July 21, 1999 700+ words
...year, it would be one of only two oral chemotherapy drugs on the market to treat colon...Partners in Manhattan, said he doubts oral chemotherapy will become a huge part of the pharmaceutical...Roche Pharmaceuticals already has an oral chemotherapy drug on the market. Xeloda is used...
BioAlliance Pharma Presents Results for Its New Oral Chemotherapy Nanoparticle...
Press release article from: Business Wire November 12, 2009 700+ words
...has presented its results on new oral chemotherapy nanoparticle formulation at the AAPS...Angeles (November 8 to 12, 2009). Oral chemotherapy is a great challenge and its success...Nanoparticles (SRN) formulation, oral chemotherapy can maintain optimum drug plasma...
Findings from National Surgical Adjuvant Breast and Bowel Project (NSABP)...
Press release article from: PR Newswire June 6, 2004 700+ words
...NSABP Protocol C-06 that compared oral chemotherapy (UFT/leucovorin) with intravenous...reinforce the growing importance of oral chemotherapy in the treatment of colorectal cancer...this evidence supports the use of oral chemotherapy at a much earlier stage in the disease...
Scott-Levin and Jstreetdata.com Launch Contemporary Issues in Oncology: Oral...
Press release article from: Business Wire May 1, 2001 700+ words
...Contemporary Issues in Oncology: Oral Chemotherapy, an Internet-based study that...oncologists expected to use more oral chemotherapy agents this year. -- The three...current and expected future use of oral chemotherapy. -- Physician assessments of patient...
For more facts and information, see all results

Source: HighBeam Research, NSABP protocol C-06: Oral chemotherapy equally effective and...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA